Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Feagan

Showing results (411-420 of 464) with videos related to

Pageof 47
Sort By:
Lancet (London, England)|July 20, 2025
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trialsRemo Panaccione, Brian G Feagan, Anita Afzali, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2021
An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trialsRocio Sedano, Christopher Ma, Rish K Pai, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2019
Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trialsRish K Pai, David E Kleiner, John Hart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 17, 2025
Development and External Validation of an Endoscopic and Histologic Pouchitis Assessment Tool: The Atlantic Pouchitis IndexRocio Sedano, Christopher Ma, Malcolm Hogan, et al.
Hepatology (Baltimore, Md.)|March 25, 2022
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity scoreRish K Pai, Vipul Jairath, Malcolm Hogan, et al.
Gastroenterology|August 9, 2020
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative ColitisMatthew R Henn, Edward J O'Brien, Liyang Diao, et al.
Gastroenterology|March 27, 2013
The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitisBrian G Feagan, William J Sandborn, Geert D'Haens, et al.
Gastroenterology|September 3, 2019
Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic ReviewIlyssa O Gordon, Dominik Bettenworth, Arne Bokemeyer, et al.
Alimentary Pharmacology & Therapeutics|December 24, 2019
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's diseaseParambir S Dulai, Aurelien Amiot, Laurent Peyrin-Biroulet, et al.
Gastroenterology|February 12, 2020
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's DiseaseWilliam J Sandborn, Brian G Feagan, Edward V Loftus, et al.
Pageof 47

Showing results (411-420 of 464) with videos related to

Sort By:
Pageof 47
Lancet (London, England)|July 20, 2025
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trialsRemo Panaccione, Brian G Feagan, Anita Afzali, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2021
An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trialsRocio Sedano, Christopher Ma, Rish K Pai, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2019
Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trialsRish K Pai, David E Kleiner, John Hart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 17, 2025
Development and External Validation of an Endoscopic and Histologic Pouchitis Assessment Tool: The Atlantic Pouchitis IndexRocio Sedano, Christopher Ma, Malcolm Hogan, et al.
Hepatology (Baltimore, Md.)|March 25, 2022
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity scoreRish K Pai, Vipul Jairath, Malcolm Hogan, et al.
Gastroenterology|August 9, 2020
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative ColitisMatthew R Henn, Edward J O'Brien, Liyang Diao, et al.
Gastroenterology|March 27, 2013
The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitisBrian G Feagan, William J Sandborn, Geert D'Haens, et al.
Gastroenterology|September 3, 2019
Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic ReviewIlyssa O Gordon, Dominik Bettenworth, Arne Bokemeyer, et al.
Alimentary Pharmacology & Therapeutics|December 24, 2019
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's diseaseParambir S Dulai, Aurelien Amiot, Laurent Peyrin-Biroulet, et al.
Gastroenterology|February 12, 2020
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's DiseaseWilliam J Sandborn, Brian G Feagan, Edward V Loftus, et al.
Pageof 47